Skip to content

The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis.

Meta-analysis · Medicine (Baltimore) · 2016. Source record refreshed; an explanation has not been reviewed.

Meta-analysisSource: PubMed · PMID 27861357

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients: A systematic review and meta-analysis.

Ye Z, Lu H, Guo W et al.
Medicine (Baltimore) · 2016

PubMed ID
27861357
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.